INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for bile duct cancer patients who stop responding to chemo
Disease control CompletedThis study tested a combination treatment for people with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) whose cancer continued to grow after standard chemotherapy. The treatment combined a targeted drug (apatinib), an immunotherapy (PD-1 antibody), and a p…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
New targeted drug shows promise for hard-to-treat bile duct cancer
Disease control CompletedThis study tested a new drug called RLY-4008 in 490 adults with advanced bile duct cancer or other solid tumors that have specific FGFR2 gene changes. The drug is designed to block FGFR2, which can help slow or shrink tumors. The goal was to find the best dose and see how well it…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Elevar Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Bubble-Popping ultrasound may boost bile duct cancer radiotherapy
Diagnosis CompletedThis study tested whether a special ultrasound using gas microbubbles can predict how well bile duct cancer responds to targeted radiotherapy. Sixteen adults with bile duct tumors received the ultrasound before and during treatment. Researchers also explored if popping the microb…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated May 18, 2026 12:03 UTC